Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.vrml · Entity 7871 | Director | June 05, 2020 | June 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date June 05, 2020 · Filed June 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 473,461 |
Reported balance
After 2020-06-05 transaction · row 1
1 source rowRow 1 · 2020-06-05 · Other · Acquired 11,250 · Balance 473,461 |
| Warrants to acquire Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.80 · Expires 2020-06-09 | Direct | 0 |
Reported balance
After 2020-06-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-05 · Other · Disposed 11,250 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2020 Filed Jun 10, 2020 00:28 UTC | Aspira Women's Health Inc. vrml · Entity 7871 | OtherWarrants to acquire Common Stock · Derivative | 11,250 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001294046-20-000002 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:28 UTC | Aspira Women's Health Inc. vrml · Entity 7871 | OtherCommon Stock | 11,250 | $1.80 | $20,250.00 |
DisclosureSEC source: 0001294046-20-000002 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,461 Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:43 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 113,300 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001294046-20-000001 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,300 Underlying: Common Stock · 113,300 shares Expires 2030-03-19 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:43 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 65,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001294046-20-000001 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,211 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:21 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 91,451 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001294046-19-000001 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,451 Underlying: Common Stock · 91,451 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:21 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock | 34,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001294046-19-000001 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,055 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Apr 8, 2019 12:25 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 91,451 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001294046-19-000002 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,451 Underlying: Common Stock · 91,451 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Apr 8, 2019 12:25 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 34,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001294046-19-000002 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,055 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:33 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 73,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001294046-18-000001 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,207 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:40 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 22,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001294046-17-000002 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,607 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2017, 25% of the restricted stock units will vest on September 1, 2017 and 25% of the restricted stock units will vest on December 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 20:52 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseWarrants (Right to buy) · Derivative | 11,250 | $0.13 Strike: $1.80 | $1,406.25 |
DisclosureSEC source: 0001294046-17-000001 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2022-02-17 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 20:52 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 15,000 | $1.40 | $21,000.00 |
DisclosureSEC source: 0001294046-17-000001 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,922 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.